Former President Donald Trump on Sunday introduced a new policy he claims will significantly reduce prescription drug prices in the United States by as much as 30 to 80 percent.
In a social media post, Trump stated that the initiative would help balance global drug pricing and “bring FAIRNESS TO AMERICA.” He said the policy would be enacted through an executive order set to be signed at 9:00 am (1300 GMT) on Monday.
The proposal involves implementing a “MOST FAVORED NATION’S” policy, which would link the prices of drugs sold in the U.S. to the lowest price paid by any other country for the same medication. According to Trump, this would lead to a drop in domestic prices, while costs could increase in other countries to even out the global pricing landscape.
“Most favored nation” status, rooted in World Trade Organization rules, is designed to ensure countries are treated equally in trade, minimizing price disparities and unfair practices.
The White House has yet to provide specific details about the new plan.
Trump had previously attempted to tackle high drug prices during his 2017–2021 term, but those efforts were blocked by resistance from pharmaceutical companies.
Just last month, he signed an executive order allowing states greater freedom to source medications internationally and streamline drug price negotiations.
